{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:17:29Z","timestamp":1793092649260,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jtct.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T04:26:08Z","timestamp":1709785568000},"page":"546.e1-546.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Gut Immunomodulation with Vedolizumab prior to Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9891-6759","authenticated-orcid":false,"given":"Yogi","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7901-3159","authenticated-orcid":false,"given":"Karol","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleixo","family":"Muise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-1977","authenticated-orcid":false,"given":"Joerg","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Yueh","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy Hong-Diep","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-6391","authenticated-orcid":false,"given":"Eyal","family":"Grunebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2024.03.006_bib0001","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.bbmt.2020.01.004","article-title":"Prevention and treatment of acute graft-versus-host disease in children, adolescents and young adults","volume":"26","author":"Gatza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.03.006_bib0002","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bbmt.2016.05.022","article-title":"French Society of Bone Marrow Transplantation and Cell Therapy. Influence of previous inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis","volume":"22","author":"Rabian","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.03.006_bib0003","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10875-019-00659-8","article-title":"submitted on behalf of the Primary Immune Deficiency Treatment Consortium. Chronic granulomatous disease-associated IBD resolves and does not adversely impact survival following allogeneic HCT","volume":"39","author":"Marsh","year":"2019","journal-title":"J Clin Immunol"},{"issue":"13","key":"10.1016\/j.jtct.2024.03.006_bib0004","article-title":"Vedolizumab for acute gastrointestinal graft-versus-host disease: a systematic review and meta-analysis","author":"Li","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.jtct.2024.03.006_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2468-1253(22)00307-7","article-title":"Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study","volume":"8","author":"Atia","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jtct.2024.03.006_bib0006","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41588-021-00803-4","article-title":"Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice","volume":"53","author":"Wang","year":"2021","journal-title":"Nat Genet."},{"key":"10.1016\/j.jtct.2024.03.006_bib0007","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s00431-021-04063-6","article-title":"Safety and effectiveness of vedolizumab in pediatric patients with inflammatory bowel disease: an observational multicentre Spanish study","volume":"180","author":"Garcia-Romero","year":"2021","journal-title":"Eur Pediatr"},{"key":"10.1016\/j.jtct.2024.03.006_bib0008","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbmt.2016.10.009","article-title":"Targeting integrin \u03b14\u03b27 in steroid-refractory intestinal graft-versus-host disease","volume":"23","author":"Fl\u00f8isand","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.03.006_bib0009","doi-asserted-by":"crossref","first-page":"e28968","DOI":"10.1002\/pbc.28968","article-title":"\u03b14\u03b27 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease","volume":"68","author":"Ibrahimova","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2024.03.006_bib0010","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1182\/bloodadvances.2019000893","article-title":"Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Chen","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.jtct.2024.03.006_bib0011","series-title":"Presented at: 2023 Transplantation & Cellular Therapy Meetings. February 15-19","author":"Chen","year":"2023"},{"key":"10.1016\/j.jtct.2024.03.006_bib0012","doi-asserted-by":"crossref","first-page":"345","DOI":"10.17219\/acem\/146321","article-title":"Vedolizumab in highly resistant acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation: a single-center pediatric series","volume":"31","author":"Rosa","year":"2022","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jtct.2024.03.006_bib0013","first-page":"795","article-title":"Vedolizumab: an emerging treatment option for pediatric inflammatory bowel disease","volume":"26","author":"Shah","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jtct.2024.03.006_bib0014","doi-asserted-by":"crossref","first-page":"e30061","DOI":"10.1002\/pbc.30061","article-title":"Vedolizumab for pediatric patients with gastrointestinal acute graft-versus-host-disease","volume":"70","author":"Aldouby Bier","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2024.03.006_bib0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bjh.18497","article-title":"Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation","volume":"200","author":"Moser","year":"2023","journal-title":"Br J Haematol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T19:39:41Z","timestamp":1746128381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2666636724002562"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.03.006","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut Immunomodulation with Vedolizumab prior to Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}